Physician profile

Jeffrey D Sharon

Otolaryngology · St. Louis, MO

NPI 1447489968

$18,345.30

in general payments reported to CMS, 2019-2025

10 companies · $1,307 in 2025

The $1,307 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).

See the full distribution for Otolaryngology

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$2,169.84
Food and Beverage$2,162.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Oticon Medical, LLC $10,762.53 2019-2021
Stryker Corporation $5,074.21 2021-2024 Core, N/A
Advanced Bionics, LLC $1,028.05 2019-2025 Hires Ultra Ci Hifocus Ms Electrode
Cochlear Americas $593.74 2019-2025 Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha
Iotamotion, INC. $212.20 2024-2025 Iotasoft
Med-El Corporation $206.66 2019-2022
Integra Lifesciences Corporation $196.57 2025 Relieva Spinplus Nav, Trudi Probe, Inspira Air
Lilly USA, LLC $185.04 2021-2024 Emgality
Abbvie INC. $59.46 2024
Inspire Medical Systems, INC. $26.84 2025 Inspire

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$19,832.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey D Sharon

$18,345.30

in general payments reported 2019-2025

Years
2019-2025
Top company
Lilly USA, LLC
Context
The $1,307 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).

https://glasscript.com/doctor/660727/jeffrey-d-sharon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.